v3.26.1
Condensed Consolidated Statements of Stockholders Deficit (Unaudited) - USD ($)
Total
Common stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Controlling Interest
Balance, shares at Dec. 31, 2024   4,804,874        
Balance, amount at Dec. 31, 2024 $ (26,107,736) $ 4,805 $ 204,246,287 $ 385,631 $ (229,544,343) $ (1,200,116)
Common stock issued for cash, net of issuance costs, shares   227,622        
Common stock issued for cash, net of issuance costs, amount 2,384,654 $ 227 2,384,427 0 0 0
Common stock issued for settlement of RSUs, shares   4,878        
Common stock issued for settlement of RSUs, amount 0 $ 5 (5) 0 0 0
Stock-based compensation 347,801 $ 0 347,801 0    
Stock-based compensation in relation to modification of options 103,573   103,573      
Tax withholdings paid related to stock-based compensation (24,411)   (24,411)      
Foreign currency translation (253,929)     (253,929)    
Net loss for the period (5,476,627)       (5,423,759) (52,868)
Balance, shares at Mar. 31, 2025   5,037,374        
Balance, amount at Mar. 31, 2025 (29,026,675) $ 5,037 207,057,672 131,702 (234,968,102) (1,252,984)
Balance, shares at Dec. 31, 2024   4,804,874        
Balance, amount at Dec. 31, 2024 (26,107,736) $ 4,805 204,246,287 385,631 (229,544,343) (1,200,116)
Net loss for the period (11,790,697)          
Balance, shares at Jun. 30, 2025   5,199,101        
Balance, amount at Jun. 30, 2025 (33,098,322) $ 5,199 209,875,929 (444,294) (241,252,180) (1,282,976)
Balance, shares at Mar. 31, 2025   5,037,374        
Balance, amount at Mar. 31, 2025 (29,026,675) $ 5,037 207,057,672 131,702 (234,968,102) (1,252,984)
Common stock issued for cash, net of issuance costs, shares   16,078        
Common stock issued for cash, net of issuance costs, amount 60,604 $ 16 60,588      
Common stock issued for settlement of RSUs, shares   47,735        
Common stock issued for settlement of RSUs, amount   $ 48 (48)      
Stock-based compensation 812,045   812,045      
Tax withholdings paid related to stock-based compensation (55,057)   (55,057)      
Foreign currency translation (575,996)     (575,996)    
Net loss for the period (6,314,070)       (6,284,078) (29,992)
Common stock issued for cash, in respect of warrant shares, shares   97,914        
Common stock issued for cash, in respect of warrant shares, amount 1,958 $ 98 1,860      
Issuance of warrants in connection with convertible note offering 1,998,869   1,998,869      
Balance, shares at Jun. 30, 2025   5,199,101        
Balance, amount at Jun. 30, 2025 (33,098,322) $ 5,199 209,875,929 (444,294) (241,252,180) (1,282,976)
Balance, shares at Dec. 31, 2025   6,288,988        
Balance, amount at Dec. 31, 2025 (35,592,811) $ 6,289 218,943,759 (295,071) (252,901,370) (1,346,418)
Common stock issued for cash, net of issuance costs, shares   1,000,681        
Common stock issued for cash, net of issuance costs, amount 5,173,804 $ 1,001 5,172,803 0 0 0
Common stock issued for settlement of RSUs, shares   25,915        
Common stock issued for settlement of RSUs, amount 0 $ 26 (26) 0 0 0
Stock-based compensation 224,982 0 224,982 0 0 0
Tax withholdings paid related to stock-based compensation (15,706) 0 (15,706) 0 0 0
Foreign currency translation 134,307 0 0 134,307 0 0
Net loss for the period (6,703,557) 0 0 0 (6,664,774) (38,783)
Issuance of warrants in connection with convertible note offering 615,852 $ 0 615,852 0 0 0
Fair value of convertible note settlement 2,803,200   2,803,200      
Common stock issued for settlement of convertible note repayments, shares   615,028        
Common stock issued for settlement of convertible note repayments, amount 0 $ 615 (615) 0 0 0
Balance, shares at Mar. 31, 2026   7,930,612        
Balance, amount at Mar. 31, 2026 (33,359,929) $ 7,931 227,744,249 (160,764) (259,566,144) (1,385,201)
Balance, shares at Dec. 31, 2025   6,288,988        
Balance, amount at Dec. 31, 2025 (35,592,811) $ 6,289 218,943,759 (295,071) (252,901,370) (1,346,418)
Net loss for the period (14,018,820)          
Balance, shares at Jun. 30, 2026   12,044,339        
Balance, amount at Jun. 30, 2026 (33,539,360) $ 12,044 235,263,755 (88,451) (267,352,291) (1,374,417)
Balance, shares at Mar. 31, 2026   7,930,612        
Balance, amount at Mar. 31, 2026 (33,359,929) $ 7,931 227,744,249 (160,764) (259,566,144) (1,385,201)
Common stock issued for cash, net of issuance costs, shares   3,425,885        
Common stock issued for cash, net of issuance costs, amount 5,458,442 $ 3,425 5,455,017 0 0 0
Common stock issued for settlement of RSUs, shares   527        
Common stock issued for settlement of RSUs, amount 0 $ 1 (1) 0 0 0
Stock-based compensation 238,002 0 238,002 0 0 0
Tax withholdings paid related to stock-based compensation (125) 0 (125) 0 0 0
Foreign currency translation 72,313 0 0 72,313 0 0
Net loss for the period (7,315,263) $ 0 0   (7,326,047) 10,784
Fair value of convertible note settlement 1,367,200   1,367,200      
Common stock issued for settlement of convertible note repayments, shares   687,315        
Common stock issued for settlement of convertible note repayments, amount 0 $ 687 (687) 0 0 0
Deemed dividend - down round provision in warrants 0 $ 0 460,100 0 (460,100) 0
Balance, shares at Jun. 30, 2026   12,044,339        
Balance, amount at Jun. 30, 2026 $ (33,539,360) $ 12,044 $ 235,263,755 $ (88,451) $ (267,352,291) $ (1,374,417)